{"AllianceGenome": "15562", "HGNC": "15562", "MIM": "605509", "_id": "27179", "_version": 1, "accession": {"genomic": ["AC016724.11", "AY944686.1", "BN000002.1", "CH471217.1", "CP068276.2", "NC_000002.12", "NC_060926.1"], "protein": ["AAF25211.1", "AAI07043.1", "AAI07044.1", "AAX20113.1", "AAY14988.1", "BAG36836.1", "CAD29875.1", "EAW73614.1", "NP_055255.1", "Q9UHA7.1", "XP_005263696.1", "XP_011509267.1", "XP_016859295.1", "XP_054197362.1", "XP_054197363.1", "XP_054197364.1"], "rna": ["AF201831.1", "AK314149.1", "BC107042.1", "BC107043.1", "NM_014440.3", "XM_005263639.3", "XM_011510965.2", "XM_017003806.2", "XM_054341387.1", "XM_054341388.1", "XM_054341389.1"], "translation": [{"protein": "AAF25211.1", "rna": "AF201831.1"}, {"protein": "BAG36836.1", "rna": "AK314149.1"}, {"protein": "XP_054197363.1", "rna": "XM_054341388.1"}, {"protein": "XP_005263696.1", "rna": "XM_005263639.3"}, {"protein": "AAI07043.1", "rna": "BC107042.1"}, {"protein": "XP_016859295.1", "rna": "XM_017003806.2"}, {"protein": "XP_054197364.1", "rna": "XM_054341389.1"}, {"protein": "XP_054197362.1", "rna": "XM_054341387.1"}, {"protein": "AAI07044.1", "rna": "BC107043.1"}, {"protein": "NP_055255.1", "rna": "NM_014440.3"}, {"protein": "XP_011509267.1", "rna": "XM_011510965.2"}]}, "alias": ["FIL1", "FIL1(EPSILON)", "FIL1E", "IL-1F6", "IL1(EPSILON)", "IL1F6"], "ensembl": {"gene": "ENSG00000136694", "protein": "ENSP00000259211", "transcript": "ENST00000259211", "translation": [{"protein": "ENSP00000259211", "rna": "ENST00000259211"}], "type_of_gene": "protein_coding"}, "entrezgene": "27179", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 6.17811611, "exp_mis": 51.6359954, "exp_syn": 22.6406911, "lof_z": 0.0709847185050242, "mis_z": -0.501249454361821, "mu_lof": 3.97321103926e-07, "mu_mis": 4.40941700366e-06, "mu_syn": 1.85030180093e-06, "n_lof": 6.0, "n_mis": 59.0, "n_syn": 22.0, "p_li": 0.000123309813533248, "p_null": 0.609665125009436, "p_rec": 0.390211565177031, "syn_z": 0.0834742557127111}, "bp": 477, "cds_end": 113765621, "cds_start": 113763448, "n_exons": 4, "nonpsych": {"exp_lof": 5.5092489, "exp_mis": 46.6530176, "exp_syn": 20.4094673, "lof_z": 0.213076659937565, "mis_z": -0.542538553609771, "mu_lof": 3.97321103926e-07, "mu_mis": 4.40941700366e-06, "mu_syn": 1.85030180093e-06, "n_lof": 5.0, "n_mis": 54.0, "n_syn": 21.0, "p_li": 0.000718272993423203, "p_null": 0.509375397408484, "p_rec": 0.489906329598093, "syn_z": -0.08229804982973}, "nontcga": {"exp_lof": 5.67582127, "exp_mis": 47.4970735, "exp_syn": 20.8213905, "lof_z": -0.13423057001654, "mis_z": -0.397804884034647, "mu_lof": 3.97321103926e-07, "mu_mis": 4.40941700366e-06, "mu_syn": 1.85030180093e-06, "n_lof": 6.0, "n_mis": 53.0, "n_syn": 21.0, "p_li": 9.32186847223661e-05, "p_null": 0.658170716510287, "p_rec": 0.341736064804991, "syn_z": -0.0247841041085781}, "transcript": "ENST00000259211.6"}, "exons": [{"cdsend": 113008044, "cdsstart": 113005871, "chr": "2", "position": [[113005458, 113005881], [113005973, 113006087], [113006597, 113006737], [113007831, 113008044]], "strand": 1, "transcript": "NM_014440", "txend": 113008044, "txstart": 113005458}], "exons_hg19": [{"cdsend": 113765621, "cdsstart": 113763448, "chr": "2", "position": [[113763035, 113763458], [113763550, 113763664], [113764174, 113764314], [113765408, 113765621]], "strand": 1, "transcript": "NM_014440", "txend": 113765621, "txstart": 113763035}], "generif": [{"pubmed": 11466363, "text": "IL-1 epsilon, an interleukin-1 agonist, activates NF-kappa B through the orphan IL-1 receptor-related protein 2 and may constitute part of an independent signaling system present in human epithelial barriers."}, {"pubmed": 12110411, "text": "A functional IL-6 polymorphism has been weakly associated with level of peak bone mineral density and the rate of forearm trabecular postmenopausal bone loss in a cohort of women."}, {"pubmed": 14734551, "text": "IL-1F6 and IL-1F8, in addition to IL-1F9, activate the pathway leading to NF-kappaB in an IL-1Rrp2-dependent manner in Jurkat cells"}, {"pubmed": 17908936, "text": "Dysregulated expression in transgenic mice can promote cutaneous inflammation, revealing potential novel targets for the treatment of inflammatory skin disorders."}, {"pubmed": 18484691, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20141484, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21242515, "text": "Expression of IL-1F6 is increased in human plaque psoriasis skin and in the lesional skin of transgenic mice compared with monotransgenic littermates."}, {"pubmed": 21965679, "text": "Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity"}, {"pubmed": 23268368, "text": "The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium."}, {"pubmed": 24061617, "text": "Results show that IL-36alpha expression may play a pivotal role in determining the prognosis of hepatocellular carcinoma (HCC)."}, {"pubmed": 24829417, "text": "IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin"}, {"pubmed": 25550854, "text": "IL-36alpha was highly expressed in nearly half of all colorectal cancer patients. Low expression level of IL-36alpha correlated with larger tumor size and advanced cancer stage. Low expression of IL-36alpha resulted in a poor prognosis of colorectal cancer patients."}, {"pubmed": 25700962, "text": "increases maturation of monocyte-derived dendritic cells"}, {"pubmed": 25902739, "text": "IL36A-IL36R axis is modulated in patients with primary Sjogren's syndrome."}, {"pubmed": 26516833, "text": "Study shows that plasma concentrations of IL-36alpha and IL-36gamma are overexpressed in active systemic lupus erythematosus patients and that IL-36alpha has a substantial pro-inflammatory effect through regulation of IL-6 and CXCL8 production."}, {"pubmed": 26560022, "text": "IL-36alpha acts as a pro-inflammatory cytokine at cartilage level, by increasing the expression of markers of inflammation and cartilage catabolism."}, {"pubmed": 26752465, "text": "Increased Expression of Interleukin-36 is associated with Inflammatory Bowel Disease."}, {"pubmed": 26813344, "text": "The data identify a novel role for IL-36 signaling in colonic inflammation and indicate that the IL-36R pathway may represent a novel target for therapeutic intervention."}, {"pubmed": 28099250, "text": "Data suggest that interleukin-36alpha (IL-36alpha) plays an important role in the pathophysiology of inflammation and fibrosis in the pancreas via an autocrine function."}, {"pubmed": 28621240, "text": "IL-36a was displayed to be able to suppress the growth of epithelial ovarian cancer cells in our setting, which is suggestive of its druggable potential in curing the epithelial ovarian cancer and that upregulation of IL-36a was found to be capable of inhibiting the growth of epithelial ovarian cancer cells."}, {"pubmed": 28811383, "text": "With a focus on the skin as a target for microbial and viral invasion, the current knowledge of IL-36: IL-36alpha, IL-36beta and IL-36gamma, functions is reviewed. One physiological function of the IL-36smay be to counteract microbial immune evasion. [Review]"}, {"pubmed": 28869889, "text": "IL-36-mediated IL-6 and CXCL8 production in human lung fibroblasts and bronchial epithelial cells may be involved in pulmonary inflammation especially caused by bacterial or viral infections."}, {"pubmed": 29142248, "text": "The molecular analysis revealed strong cooperative effects of IL-17A and IL-36 cytokines in regulating target genes, which was dependent on the proteolytic activation of the latter. Together these findings suggest an amplification cycle that can be initiated by IL-17A, involving IL-36 cytokines and immune cell derived proteases and resulting in active IL-36 cytokines which synergize with IL-17A"}, {"pubmed": 29367626, "text": "The authors report that, in Mycobacterium tuberculosis-infected macrophages, IL-36 signaling modulates cholesterol biosynthesis and efflux via LXR."}, {"pubmed": 29571080, "text": "serum IL-36alpha levels were higher in active systemic lupus erythematosus patients and correlated with disease activity and arthritis"}, {"pubmed": 30243000, "text": "PTX3 and IL36alpha serum levels are increased in systemic lupus erythematosus patients when compared to normal control subjects"}, {"pubmed": 30852049, "text": "interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity"}, {"pubmed": 31068441, "text": "These findings highlight the relevance of TGFBR2-IL-36 interplay in joint homeostasis."}, {"pubmed": 31486687, "text": "The interleukin-36 (IL-36) pathway appears to be central to generalized pustular psoriasis (GPP) pathogenesis."}, {"pubmed": 31682009, "text": "IL36A expression is significantly downregulated in healhty palatal mucosa of smokers"}, {"pubmed": 31729440, "text": "Structural insights into heme binding to IL-36alpha proinflammatory cytokine."}, {"pubmed": 31736959, "text": "Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases."}, {"pubmed": 32013927, "text": "IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?"}, {"pubmed": 33034926, "text": "Serum IL-36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation."}, {"pubmed": 33396613, "text": "Role of IL-36 Cytokines in the Regulation of Angiogenesis Potential of Trophoblast Cells."}, {"pubmed": 33713575, "text": "Interleukin-36alpha suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis."}, {"pubmed": 34082505, "text": "Elevated urinary IL-36alpha and IL-18 levels are associated with diabetic nephropathy in patients with type 2 diabetes mellitus."}, {"pubmed": 34185456, "text": "Association of interleukin-36alpha gene expression in Egyptian patients with systemic lupus erythematosus with organ involvement and disease activity."}, {"pubmed": 34289144, "text": "IL-36alpha and IL-36gamma expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study."}, {"pubmed": 34555640, "text": "Interleukin-36alpha inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8(+) T lymphocytes."}, {"pubmed": 34794731, "text": "Decreased serum profile of the interleukin-36alpha in polycystic ovary syndrome."}, {"pubmed": 35049442, "text": "The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its Complications."}, {"pubmed": 35667282, "text": "Interleukin-36alpha is elevated in diffuse systemic sclerosis and may potentiate fibrosis."}, {"pubmed": 35698471, "text": "IL-36 is Closely Related to Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease."}, {"pubmed": 35903102, "text": "IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic."}, {"pubmed": 38189700, "text": "Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases."}, {"pubmed": 38203575, "text": "Altered Gene Expression of IL-35 and IL-36alpha in the Skin of Patients with Atopic Dermatitis."}], "genomic_pos": {"chr": "2", "end": 113008044, "ensemblgene": "ENSG00000136694", "start": 113005459, "strand": 1}, "genomic_pos_hg19": {"chr": "2", "end": 113765621, "start": 113763038, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0002437", "qualifier": "involved_in", "term": "inflammatory response to antigenic stimulus"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006955", "pubmed": 10625660, "qualifier": "involved_in", "term": "immune response"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0010628", "qualifier": "involved_in", "term": "positive regulation of gene expression"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019221", "qualifier": "involved_in", "term": "cytokine-mediated signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032755", "qualifier": "involved_in", "term": "positive regulation of interleukin-6 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0071222", "qualifier": "involved_in", "term": "cellular response to lipopolysaccharide"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 10625660, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "located_in", "term": "cytoplasm"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005125", "qualifier": "enables", "term": "cytokine activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0005149", "pubmed": 10625660, "qualifier": "enables", "term": "interleukin-1 receptor binding"}]}, "homologene": {"genes": [[9544, 705136], [9598, 738914], [9606, 27179], [9913, 523429], [10090, 54448], [10116, 296541]], "id": 8688}, "interpro": [{"desc": "Interleukin-1 family", "id": "IPR000975", "short_desc": "IL-1_fam"}, {"desc": "Cytokine IL1/FGF", "id": "IPR008996", "short_desc": "IL1/FGF"}], "ipi": "IPI00004382", "map_location": "2q14.1", "name": "interleukin 36 alpha", "other_names": ["FIL1 epsilon", "IL-1 epsilon", "IL-1F6 (FIL-1-epsilon)", "interleukin 1 family, member 6 (epsilon)", "interleukin-1 epsilon", "interleukin-1 family member 6", "interleukin-36 alpha"], "pantherdb": {"HGNC": "15562", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1859324", "ortholog_type": "LDO", "panther_family": "PTHR10078", "taxid": 10090, "uniprot_kb": "Q9JLA2"}, {"RGD": "1306869", "ortholog_type": "LDO", "panther_family": "PTHR10078", "taxid": 10116, "uniprot_kb": "D4A1I2"}, {"Ensembl": "ENSGALG00000029940", "ortholog_type": "O", "panther_family": "PTHR10078", "taxid": 9031, "uniprot_kb": "O73909"}, {"ZFIN": "ZDB-GENE-040702-2", "ortholog_type": "O", "panther_family": "PTHR10078", "taxid": 7955, "uniprot_kb": "A0A0R4IYF1"}], "uniprot_kb": "Q9UHA7"}, "pathway": {"kegg": {"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-446652", "name": "Interleukin-1 family signaling"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-9014826", "name": "Interleukin-36 pathway"}]}, "pdb": "6HPI", "pfam": "PF00340", "pharmgkb": "PA38389", "pharos": {"target_id": 17640, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF264251", "relationship": "is"}, {"id": "GNF264252", "relationship": "is"}, {"id": "GNF264253", "relationship": "is"}, {"id": "GNF264254", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF084930", "relationship": "is"}, {"id": "GNF084931", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053706", "relationship": "is"}, {"id": "GNF058478", "relationship": "is"}, {"id": "GNF073705", "relationship": "is"}, {"id": "GNF078796", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066763", "relationship": "is"}, {"id": "GNF066764", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF277328", "relationship": "is"}, {"id": "GNF277329", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF336975", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF101444", "relationship": "is"}, {"id": "GNF141099", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1"], "protein": ["NP_055255.1", "XP_005263696.1", "XP_011509267.1", "XP_016859295.1", "XP_054197362.1", "XP_054197363.1", "XP_054197364.1"], "rna": ["NM_014440.3", "XM_005263639.3", "XM_011510965.2", "XM_017003806.2", "XM_054341387.1", "XM_054341388.1", "XM_054341389.1"], "translation": [{"protein": "XP_054197363.1", "rna": "XM_054341388.1"}, {"protein": "XP_005263696.1", "rna": "XM_005263639.3"}, {"protein": "XP_016859295.1", "rna": "XM_017003806.2"}, {"protein": "XP_054197364.1", "rna": "XM_054341389.1"}, {"protein": "XP_054197362.1", "rna": "XM_054341387.1"}, {"protein": "NP_055255.1", "rna": "NM_014440.3"}, {"protein": "XP_011509267.1", "rna": "XM_011510965.2"}]}, "reporter": {"HG-U133_Plus_2": "221404_at", "HTA-2_0": "TC02000716.hg.1", "HuEx-1_0": "2501140", "HuGene-1_1": "8044548", "HuGene-2_1": "16884602"}, "retired": 83004, "summary": "The protein encoded by this gene is a cytokine that can activate NF-kappa-B and MAPK signaling pathways to generate an inflammatory response. The encoded protein functions primarily in skin and demonstrates increased expression in psoriasis. In addition, decreased expression of this gene has been linked to a poor prognosis in both hepatocellular carcinoma and colorectal cancer patients. [provided by RefSeq, Nov 2015].", "symbol": "IL36A", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1423574"}, "unigene": "Hs.278910", "uniprot": {"Swiss-Prot": "Q9UHA7"}, "wikipedia": {"url_stub": "IL1F6"}}